Fernanda Damian

993 total citations
10 papers, 41 citations indexed

About

Fernanda Damian is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fernanda Damian has authored 10 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fernanda Damian's work include Endometrial and Cervical Cancer Treatments (3 papers), Cervical Cancer and HPV Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Fernanda Damian is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Cervical Cancer and HPV Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Fernanda Damian collaborates with scholars based in Brazil, United States and Spain. Fernanda Damian's co-authors include Andréia Cristina de Melo, Ana Oaknin, Melissa Mathias, Austin Miller, Domenica Lorusso, Chang Cl, Vanessa Samouëlian, Alla Lisyanskaya, Shunji Takahashi and Matthew G. Fury and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and Annals of Oncology.

In The Last Decade

Fernanda Damian

10 papers receiving 40 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernanda Damian Brazil 4 23 14 13 12 10 10 41
Alejandro Molina Alavez Japan 2 30 1.3× 15 1.1× 20 1.5× 14 1.2× 17 1.7× 3 51
Fernando Contreras Mejía Colombia 4 20 0.9× 26 1.9× 9 0.7× 19 1.6× 4 0.4× 13 47
Christine Meder France 4 14 0.6× 13 0.9× 12 0.9× 17 1.4× 9 0.9× 7 51
Dimitrios Zouzoulas Greece 6 14 0.6× 31 2.2× 15 1.2× 7 0.6× 7 0.7× 22 83
Nawaz Walji United Kingdom 4 17 0.7× 16 1.1× 14 1.1× 10 0.8× 15 1.5× 6 52
Anne-Marie Hacker United Kingdom 3 15 0.7× 28 2.0× 18 1.4× 19 1.6× 8 0.8× 8 45
Coriolan Lebreton France 5 44 1.9× 16 1.1× 11 0.8× 6 0.5× 12 1.2× 28 76
Igor Pilić Serbia 5 11 0.5× 24 1.7× 22 1.7× 5 0.4× 12 1.2× 18 61
M. Panadés United Kingdom 5 18 0.8× 26 1.9× 21 1.6× 19 1.6× 22 2.2× 7 60
MJ Battista Germany 4 17 0.7× 11 0.8× 22 1.7× 4 0.3× 6 0.6× 11 49

Countries citing papers authored by Fernanda Damian

Since Specialization
Citations

This map shows the geographic impact of Fernanda Damian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernanda Damian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernanda Damian more than expected).

Fields of papers citing papers by Fernanda Damian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernanda Damian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernanda Damian. The network helps show where Fernanda Damian may publish in the future.

Co-authorship network of co-authors of Fernanda Damian

This figure shows the co-authorship network connecting the top 25 collaborators of Fernanda Damian. A scholar is included among the top collaborators of Fernanda Damian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernanda Damian. Fernanda Damian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Oliveira, Regina Costa de, José Bines, Giuliano Santos Borges, et al.. (2025). Cancer patients’ views on clinical research in Brazil: Concerns, knowledge, and misconceptions—A national survey.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
2.
Lorusso, Domenica, Ana Oaknin, Giuliano Santos Borges, et al.. (2024). Combination of cemiplimab and ISA101b vaccine for the treatment of recurrent/metastatic HPV16 cervical cancer.. Journal of Clinical Oncology. 42(16_suppl). 5522–5522. 4 indexed citations
3.
Fein, Luis, Nicolas Lazaretti, John R. Benfield, et al.. (2023). Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate. Clinical Drug Investigation. 43(9). 699–706. 3 indexed citations
4.
Damian, Fernanda, Andréia Cristina de Melo, Graziela Zibetti Dal Molin, et al.. (2023). A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018.. Journal of Clinical Oncology. 41(16_suppl). 5514–5514. 2 indexed citations
5.
Damian, Fernanda, et al.. (2022). Impact of hydronephrosis and kidney function on survival in newly diagnosed advanced cervical cancer. Gynecologic Oncology Reports. 39. 100934–100934. 3 indexed citations
7.
Tewari, Krishnansu S., Bradley J. Monk, Ignace Vergote, et al.. (2021). VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma. Annals of Oncology. 32(7). 940–941. 20 indexed citations
9.
Melo, Andréia Cristina de, Aknar Calabrich, Eduardo Cronemberger, et al.. (2018). Social disparities and patients’ attitudes are associated with lower rates of cervical cancer screening in Brazil: Results of EVITA study (LACOG 0215).. Journal of Clinical Oncology. 36(15_suppl). e17510–e17510. 1 indexed citations
10.
Damian, Fernanda, et al.. (2005). EVALUATING THE DIAGNOSIS OF TUBERCULOSIS IN INDUCED SPUTUM COLLECTION AND BRONCHOALVEOLAR LAVAGE SPECIMENS. CHEST Journal. 128(4). 400S–400S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026